(514) 613 0811CONTACT US
0item(s)

You have no items in your shopping cart.

Product was successfully added to your shopping cart.

Monthly Archives: September 2021

  • Current Innovations and Computational Methods for Peptide-Protein Interactions

    Just like protein-protein interaction, the structural information needed for drug targets usually comes with limited prediction accuracy for pepPIs. Following the absence of protein co-structures, most of the clinical studies and trials tend to rely on existing information, obtained from structural databases like the Protein Data Bank – PDB, in the identification of sequence-binding motifs for peptide designs.
    Continue reading

  • What You Need To Know About Peptide and Protein-Protein Interaction

    Proteins are made up of amino acids, and they are the basic building blocks of life. Peptides are a result of amino acids, which have been coded by the genes to form peptides, which then form the various types of proteins known today. Also, proteins have a crucial role to play in a variety of biological processes, such as transportation of molecules, immune reactions, catalytic reactions, and even signal transduction between cells.
    Continue reading

  • Approaches Used To Overcome the Top Drawbacks of Peptide Drugs

    Drug delivery to patient neoplasm is an area that has experienced major challenges, and it still possesses ongoing clinical challenges. Nearly five decades ago, the research world saw the proposal of function-blocking monoclonal antibodies, as a therapy for cancer. However, these particles had large molecular sizes that made their commercial development for anti-body fragment therapies, a huge challenge. However, with improvements and advancements in technologies, they were later approved for commercialized cancer therapeutics and diagnostics, two decades later.
    Continue reading

3 Item(s)